Cetera Advisors LLC Genetic Technologies LTD Transaction History

Cetera Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.0 - $6.4 $0 - $19,200	-3,000 Reduced 17.69%	13,961 $16,000
Q2 2022 Aug 11, 2022	BUY	$0.0 - $0.01 $0 - $30	3,000 Added 21.49%	16,961 $20,000
Q1 2022 May 12, 2022	SELL	$0.0 - $0.0 $0 - $0	-6,000 Reduced 30.06%	13,961 $28,000
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.01 $0 - $199	19,961 New	19,961 $38,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.